We are live on
!
Find out more
RAM
Revere Asset Management Portfolio holdings
AUM
$195M
1-Year Est. Return
80.44%
This Fund
S&P 500
This Quarter
Est. Return
+9.75%
1 Year Est. Return
+80.44%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$284M
AUM Growth
+$19.1M
(+7.2%)
Cap. Flow
+$7.73M
Cap. Flow
% of AUM
2.72%
Top 10 Holdings %
Top 10 Hldgs %
90.38%
Holding
53
New
18
Increased
6
Reduced
7
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Direxion Daily S&P 500 Bull 2X ETF
SPUU
|
+$22.5M |
| 2 |
Eli Lilly
LLY
|
+$19.5M |
| 3 |
SPDR Gold Trust
GLD
|
+$17.7M |
| 4 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$10.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$9.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Pharmaceutical ETF
PPH
|
+$15.6M |
| 2 |
Robinhood
HOOD
|
+$12.4M |
| 3 |
DoorDash
DASH
|
+$9.76M |
| 4 |
Palantir
PLTR
|
+$9.62M |
| 5 |
MP Materials
MP
|
+$8.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.87% |
| 2 | Healthcare | 7.84% |
| 3 | Technology | 5.38% |
| 4 | Consumer Discretionary | 4.31% |
| 5 | Communication Services | 4.05% |
Similar funds
TVM
GL
SPI
MFG
OBC
SCM
BOJHT
TC
Revere Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Revere Asset Management held 53 positions worth $284M, up 7.2% from $265M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Revere Asset Management's Q4 2025 filing shows 18 new, 6 increased, 7 reduced and 20 closed positions. Its largest new stake was Direxion Daily S&P 500 Bull 2X ETF: 122,820 shares worth $22.6M. The largest sale was VanEck Pharmaceutical ETF, an estimated $15.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, up from 65% a quarter earlier, followed by Healthcare and Technology.
- Revere Asset Management's largest Q4 2025 buy was Direxion Daily S&P 500 Bull 2X ETF: 122,820 shares worth $22.6M.
- Revere Asset Management added most to State Street SPDR Portfolio S&P 500 ETF in Q4 2025, an estimated $10.7M increase.
- Revere Asset Management's biggest Q4 2025 reduction was ProShares Ultra S&P500, cutting an estimated $4.03M.
- Revere Asset Management fully exited VanEck Pharmaceutical ETF in Q4 2025, selling an estimated $15.6M.
- Revere Asset Management's ten largest holdings make up 90% of its $284M portfolio in Q4 2025.
- Revere Asset Management opened 18 new positions and closed 20 in Q4 2025.
- Revere Asset Management's portfolio value rose 7.2% quarter-over-quarter to $284M.
Based on Revere Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.